ClinicalTrials.gg
CompletedNCT04823390Updated Mar 30, 2021

Anesthetist Controlled Versus Patient-controlled Sedation: Risks and Benefits

A Phase 1 interventional study of Midazolam-Fentanyl combination in Patient Satisfaction, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 40 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-30.

Sponsored by Cairo University · Phase 1, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Sep 2019, registered Mar 2021).
Phase
Phase 1
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
All
01

Study summary

Perioperative anxiety has many hazards and should be eliminated. Patients undergoing ophthalmologic procedures often undergo it under local anesthesia. In a trial to improve patients' satisfaction sedation is given. Sedation could be given either by an anesthetist or patient-controlled methods. This study compared both methods of sedation in terms of safety, depth of sedation, and patient satisfaction.

Read the detailed description

This randomized controlled trial was conducted in Kasr Al Ainy Hospital, Ophthalmology surgeries operation theatre, Cairo University, Cairo, Egypt.

After the approval of the research ethical committee (approval number MD-18-2019) \& obtaining written informed consent from every patient, 30 patients belonging to the American society of anesthesiologists (ASA) status I, II, aging from 40 to 65 years old, both genders, co-operative patients aware of the instructions, scheduled for cataract surgery under local anesthesia were enrolled for this randomized controlled trial.

However, patients with a diagnosis of cognitive impairment or mental disorder, hypersensitivity to any of the used drugs, having any conditions contraindicating local anesthesia (e.g. Coagulation disorders) were excluded from the study.

Furthermore, patients having severe pulmonary disease e.g. (obstructive sleep apnea), patients using sedative medications within the previous month, and patients with chronic renal and cardiac disorder (e.g. chronic renal failure, heart failure) were also excluded from the study.

Patients were randomly assigned into two equal groups of 15 patients each, the anesthetist controlled group Ga (n=15) and the patient-controlled group Gp (n=15). Randomization was done using computer-generated numbers and the allocation sequence of the participants was concealed in sequentially numbered sealed opaque envelopes.

In the anesthetist controlled group Ga (n=15):

Routine preoperative assessment (proper history taking, examination, and laboratory investigations) was done to all patients as needed.

In the preoperative preparation room, intravenous access (20 gauge cannula) was obtained, premedications were given in the form of (Granitryl at a dose of 10 mcg/kg as an antiemetic and ranitidine at a dose of 0.2 mg/kg as antistress ulcer prophylaxis, they were given diluted with 0.9% sodium chloride solution over 10 minutes), 15 minutes before giving the local anesthesia. Then patients were transferred to the operating room.

In the operating room, all patients were monitored with continuous pulse oximetry, electrocardiogram, and non-invasive blood pressure measured at 10 minutes interval (the blood pressure cuff was applied on the contralateral side of the IV cannula), and oxygen support was given through nasal cannula applied near the nostrils at a flow of 5 liters per minute.

The IV sedation was started before the administration of the local anesthesia in the form of a bolus of 0.02 mg/kg of midazolam and 0.2 mcg/kg of fentanyl to all patients.

Then further doses were given as needed through the procedure according to the depth of sedation. The depth of sedation was assessed at regular intervals (every 10 minutes) using the sedation scale.

A depth of sedation level II or III on the sedation scale was targeted, level I was considered anxious and needs further doses, and more than level III was considered a risk of oversedation.

A soluset was filled with a mixture of 10 mg of midazolam and 150 mcg of fentanyl diluted with 0.9 % sodium chloride solution to complete a total volume of 50 ml. and a concentration of 0.2 mg/ml of midazolam and 3 mcg/ml of fentanyl.

The anesthetist withdrew 2 ml from the soluset and gave them to the patient according to depth of sedation.

In the patient-controlled group Gp (n=15):

Routine preoperative assessment (proper history taking, examination, and laboratory investigations) was done to all patients as needed.

In the preoperative preparation room, intravenous access (20 gauge cannula) was obtained, premedications were given in the form of (Granitryl at a dose of 10 mcg/kg as an antiemetic and ranitidine at a dose of 0.2 mg/kg as antistress ulcer prophylaxis, they were given diluted with 0.9% sodium chloride solution over 10 minutes), 15 minutes before giving the local anesthesia. Then patients were transferred to the operating room.

In the operating room, all patients were monitored with continuous pulse oximetry, electrocardiogram, and non-invasive blood pressure measured at 10 minutes interval (the blood pressure cuff was applied on the contralateral side of the IV cannula), and oxygen support was given through nasal cannula applied near the nostrils at a flow of 5 liters per minute.

The IV sedation was started before the administration of the local anesthesia in the form of a bolus of 0.02 mg/kg of midazolam and 0.2 mcg/kg of fentanyl to all patients.

Patients were instructed on how to use the PCS pump, then the pump (Accufuser) was connected to the IV cannula, patients were given the press button of the infusion pump in one hand and a clicker in the other hand.

Patients were instructed to press the button as often as they feel the need to do so, as there was a lockout interval of six minutes to limit the amount of medication, during this interval the pump will not deliver drugs regardless of the patient's attempts to press the button. The attending anesthetist was instructed to respond to the patient's question "how often should I press the button" with the answer "when you feel unsedated, anxious, irritable, not calm, afraid of the operation and you want to be more relaxed and calm just press the button". If the patient pressed the button during the permission time (after the 6 min lock-out interval), a 2 ml infusion of the drug mixture was administered IV, Otherwise, no drug was administered to the patient.

In this group, patients received a clicker, on the other hand, to press on both the pump and clicker together, every time he/she used the pump to denote the number of attempts.

The observing anesthetist present beside the patient used a stopwatch to record the time from the start of the use of the pump, and the number of the attempts that were recorded as the number of the clicks done by the patient, and so in that way the anesthetist differentiated a true attempt from a false one done during the lockout interval that was fixed at 6 minutes.

The PCS pump was of 100 ml volume, of 2 ml demand doses, 6 minutes lockout interval and of no basal rate of infusion, it was filled with a mixture of 10 mg of midazolam and 150 mcg of fentanyl diluted with 0.9 % sodium chloride solution to complete a total volume of 50 ml. and a concentration of 0.2 mg/ml of midazolam and 3 mcg/ml of fentanyl.

A demand dose of 2 ml with 6 minutes lockout time was used. The patient was unaware of the lockout period, the attending anesthetist was aware of the drug regimen to be present to intervene for adverse events.

Instruction on the use of commercially available PCS pump was given verbally by the anesthetist on the day of surgery and reinforced again in the operation room (OR).

A depth of sedation level II or III on the sedation scale was targeted, level I was considered anxious and needs further doses, and more than level III was considered a risk of oversedation.

In both groups:

The eye to be operated on was marked prior to starting the local anesthesia. The total volume of 8 ml was prepared for the peribulbar block including a mixture of 4 ml lidocaine 2%, 4 ml bupivacaine 0.5%, and 75 IU of hyaluronidase. The anesthetic solution was injected into the extraconal compartment of the eye using two 23 gauge needles with 5 ml being injected at the junction of outer one-third and inner two-thirds of the lower orbital rim and 3 ml were injected superonasally beneath the superior orbital notch. The success of the block was assessed by globe bulge, loss of ocular movements and the eye was padded 5 to 10 minutes (with intermittent pressing 5 seconds and relieve the press for 10 seconds) to enhance the spread of the anesthetic solution and prevent a rise in the intraocular pressure.

After adequate and complete muscle paralysis (assessed by the inability to move the eye in 6 directions known as a gaze), the surgical procedure was allowed by an expert surgeon.

Heart rate, blood pressure, arterial oxygen saturation, and respiratory rate were recorded as a baseline before sedation and at 10 minutes intervals.

Patients' and surgeons' satisfaction, depth of sedation, and patients' anxiety were assessed.

The OR was equipped with emergency equipment and drugs. All the equipment necessary for transformation to general anesthesia if needed at any point were also present including (analgesic, hypnotic, muscle relaxant, laryngoscope, different endotracheal tube sizes a supraglottic device, and a well-functioning anesthesia machine). This transformation would have been needed if a safety endpoint was reached.

Safety endpoints for anesthetist intervention included arterial desaturation \< 90%, for more than one minute, hypotension \< 90 mmHg systolic or 20% decrease from baseline persisting when repeating determination one minute later, inability to tolerate the procedure, oversedation, airway obstruction, and the need for general anesthesia where the anesthetist will intervene.

At the end of the procedure, the total amount of sedating drug administered was recorded, as well as the number of attempts of self-administration was recorded before discharge from the OR. The patient was transferred to the recovery room and the time to ambulation was calculated, before being discharged to the ward safely.

02

Conditions studied

  • Patient Satisfaction

Browse trials for

Keywords

  • PCS
03

In context

Patient Satisfaction

279 studies on the registry are indexed under Patient Satisfaction; 131 are open to participants now.

This study's enrollment of 30 is below the median of 91 across 213 interventional studies indexed under Patient Satisfaction.

Browse Patient Satisfaction studies →

Lead sponsor

Cairo University is the lead sponsor of 4,911 studies on the registry; 1,443 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ASA physical status I, II.
  • Age group 40-65 years old.
  • Co-operative patients aware of the instructions.

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of cognitive impairment or mental disorder.
  • Hypersensitivity to any of the used drugs.
  • Contraindication to local anesthesia e.g. Coagulation disorder.
  • Severe pulmonary disease e.g. (obstructive sleep apnea).
  • Use of sedative medications within the previous month.
  • Chronic renal and cardiac disorder e.g. (chronic renal failure, heart failure).
05

Study design

Phase
Phase 1
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Other
    Anesthetist controlled group

    15 patients undergoing cataract surgery will receive sedation given by the anesthetist together with local anesthesia according to the depth of sedation in the form of intravenous Midazolam and Fentanyl.

    Drug: Midazolam-Fentanyl combination

  • Other
    Patient-controlled group

    15 patients undergoing cataract surgery under local anesthesia will administer sedation to themselves through a pump.

    Drug: Midazolam-Fentanyl combination

Interventions

  • DrugMidazolam-Fentanyl combination

    Sedation is given to patients undergoing cataract surgery under local anesthesia

06

What researchers measure

Primary outcomes

  1. Patient satisfaction assessed by 7 point Likert scale.

    Assessed by 7 point Likert scale (ranging from 1 as minimum value and 7 as maximal value), higher value is better.

    Time frame: Intraoperative for 1 hour.

Secondary outcomes

  1. Systolic and diastolic blood pressures.

    Measured in mmHg.

    Time frame: Intraoperative for 1 hour.

  2. Surgeons' satisfaction assessed by 7 point Likert scale.

    Assessed by 7 point Likert scale (ranging from 1 as minimum value and 7 as maximal value), higher values are better.

    Time frame: Intraoperative for 1 hour.

  3. Patient's anxiety assessed by State trait anxiety inventory.

    Pre and postoperative, assessed by State-trait anxiety inventory ( a questionnaire of 40 questions), the value is according to patient's answers to the questions.

    Time frame: Intraoperative for 1 hour.

  4. Heart rate.

    Measured in beats per minute.

    Time frame: Intraoperative for 1 hour.

  5. Oxygen saturation.

    In percentage.

    Time frame: Intraoperative for 1 hour.

  6. Respiratory rate.

    In breath per minute.

    Time frame: Intraoperative for 1 hour.

  7. Time to patient ambulation in minutes.

    The time from end of procedure till the patient is safely discharged from the recovery room, higher values means there is a risk of oversedation which is worse.

    Time frame: Postoperative for up to 1 hour.

07

Study locations

1 site
  • Faculty Of Medicine Kasr Al-Ainy Cairo University
    Cairo, Cairo Governorate 11865, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 30, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04823390
Lead sponsor
Cairo University
Responsible party
Mohamed Ahmed Shamma (Assistant lecturer of anaesthesia, surgical ICU and pain management kasr al aini, Cairo University) — Principal investigator
First posted
Mar 30, 2021
Start date
Sep 14, 2019
Primary completion
Feb 20, 2021
Completion
Feb 24, 2021
Last update
Mar 30, 2021

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion